Project details
- Project period
- 1 Aug 2025 - 31 Jul 2029
- Total cost
- €5 499 999,25
- Global Health EDCTP3 funding
- €5 499 999,25
- Call identifier
- HORIZON_HORIZON-JU-GH-EDCTP3-2024-01-03-two-stage
- Status
- In progress
- Project type
- Research and Innovation Actions (RIA)
- Disease area
- Neglected infectious diseases
- Intervention type
- Therapies
Consortium map
Coordinator
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER
- Location
- LONDON, United Kingdom
- EU contribution
- €859 060,00
- Total cost
- €859 060,00
Scientific project leader
ARMAUER HANSEN RESEARCH INSTITUTE
Location: Addis Ababa, Ethiopia
Beneficiaries
UPPSALA UNIVERSITET
- Location
- Uppsala, Sweden
- EU contribution
- €449 061,25
- Total cost
- €449 061,25
ARMAUER HANSEN RESEARCH INSTITUTE
- Location
- Addis Ababa, Ethiopia
- EU contribution
- €1 642 752,50
- Total cost
- €1 642 752,50
ARBAMINCH UNIVERSITY*AMU
- Location
- Arba Minch, Ethiopia
- EU contribution
- €520 008,75
- Total cost
- €520 008,75
WOLLO UNIVERSITY
- Location
- DESSIE, Ethiopia
- EU contribution
- €520 008,75
- Total cost
- €520 008,75
STELLENBOSCH UNIVERSITY
- Location
- STELLENBOSCH, South Africa
- EU contribution
- €284 816,75
- Total cost
- €284 816,75
INSTITUUT VOOR TROPISCHE GENEESKUNDE
- Location
- ANTWERPEN, Belgium
- EU contribution
- €1 224 291,25
- Total cost
- €1 224 291,25
Related projects
Treating epilepsy caused by parasite infection The NeuroSolve project is evaluating a new treatment for patients who develop epileptic seizures when tapeworm larvae become lodged in their...
AI detection of parasite infectionsThe MultiplexAI project is developing an easy-to-use add-on for conventional microscopes that deploys artificial intelligence (AI) models to detect...
Enhancing treatment of parasitic worm infectionsThe eWHORM project is using an innovative trial design to assess the efficacy of a promising new therapeutic, oxfendazole, against multiple...